Amyloid Beta-directed Antibody Interactions [MoA]: Side Effects & Safety Data for 2 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Amyloid Beta-directed Antibody Interactions [MoA] includes 2 drugs with a combined 2,640 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
2
Drugs in Class
2,640
Combined Reports
All Amyloid Beta-directed Antibody Interactions [MoA] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| LECANEMAB-IRMB | LECANEMAB AUTOINJECTOR | 2,469 | 82 | 474 | 3.3% |
| LECANEMAB | LEQEMBI | 171 | 27 | 101 | 15.8% |
Common Side Effects in Amyloid Beta-directed Antibody Interactions [MoA] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Headache | 399 | 1 |
| Amyloid related imaging abnormality-oedema/effusion | 346 | 9 |
| Amyloid related imaging abnormality-microhaemorrhages and haemosiderin deposits | 327 | 8 |
| Infusion related reaction | 235 | 3 |
| Chills | 205 | 1 |
| Fatigue | 178 | 0 |
| Confusional state | 142 | 4 |
| Pyrexia | 140 | 1 |
| Dizziness | 135 | 1 |
| Nausea | 124 | 3 |